References
- Bhattacharya B. Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin. Med Res Rev 2007;5:88–95.
- Brahamnkar DM, Jaiswal SB. Biopharmaceutics and pharmacokinetics: A treatise. New Delhi: Vallabh Prakashan India, 1995, 35–36.
- Rochdi M, Sabouraud A, Girre C, Venet R, Scherrmann JM. Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects. Eur J Clin Pharmacol 1994;46:351–354.
- Pascall B, Maud G, Georges D, Adelin A, Valery B, Bruno P, Didier C, Geraldine P, Luc D, Brigitte E. The effect of cyclodextrins on aqueous solubility of a new MMP inhibitor: phase solubility, 1H NMR spectroscopy and molecular modeling studies, preparation and stability study of nebulizable solutions. J Pharm Sci 2005;8:164–175.
- Szejtli J, Szente L. Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins. Eur J Pharm Biopharm 2005;61:115–125.
- Madan J, Dhiman N, Parmar VK, Sardana S, Bharatam PV, Aneja R et al. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics. Cancer Chemother Pharmacol 2010;65:537–548.
- Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 1996;85:1017–1025.
- Hoda A, Sana AM, Ola AK, Ahmed HH. Characterization of ternary complexes of meloxicam-HP-β-CD and PVP or L-arginine prepared by the spray-drying technique. Acta Pharm 2008;58:455–466.
- Baboota S, Dhaliwal M, Kohli K. Physicochemical characterization, in vitro dissolution behavior, and pharmacodynamic studies of rofecoxib-cyclodextrin inclusion compounds. preparation and properties of rofecoxib hydroxypropyl beta-cyclodextrin inclusion complex: a technical note. AAPS PharmSciTech 2005;6:E83–E90.
- de Araújo MV, Vieira EK, Lázaro GS, de Souza Conegero L, Ferreira OP, Almeida LS et al. Inclusion complexes of pyrimethamine in 2-hydroxypropyl-beta-cyclodextrin: characterization, phase solubility and molecular modelling. Bioorg Med Chem 2007;15:5752–5759.
- Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 2007;59:645–666.
- Tomren MA, Másson M, Loftsson T, Tønnesen HH. Studies on curcumin and curcuminoids XXXI. Symmetric and asymmetric curcuminoids: stability, activity and complexation with cyclodextrin. Int J Pharm 2007;338:27–34.
- Higuchi T, Connors AK. Advances in analytical chemistry and instrumentation. Adv Anal Chem Instrum 1956;4:117–212.
- Muvaffak A, Gurhan I, Hasirci N. Prolonged cytotoxic effect of colchicine released from biodegradable microspheres. J Biomed Mater Res Part B Appl Biomater 2004;71:295–304.
- Philomina D, Bharathi P, Chakkaravarthi S. Estimation of colchicine in six different species of gloriosa grown in vivo. Indian J Pharma Sci 2006;68:806–809.
- Bass AD, Probert C. Response of a transplantable lymphosarcoma to colchicine. Cancer Res 1950;10:420–422.
- Wilson LD, Verral RE. F and 1H NMR investigation of cyclodextrin-fluoro-carbon alkyl carboxylate surfactant inclusion complexes. Langmuir 1998;14:4710–4717.